Atlantic Labs 4 GmbH & Co. KG
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
through Oct 2, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Oct 2, 2025 · D | Oct 2, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | — | — | — |
| Reported amount sold | $585,750 | $564,900 | $-20,850 |
| Reported investor count | — | 2 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001013594-25-001175 · Later SEC source: 0001013594-26-001001
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- —
- Reported exemptions
- Rule 506(b), Investment Company Act Section 3(c), Investment Company Act Section 3(c)(7)
- Reported amount sold
- $564,900
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Form D filings (2)
-
0001013594-26-001001D/A · Oct 2, 2026 · Pooled Investment FundSold: $564,900
Compared with 0001013594-25-001175:
- Reported amount sold: $585,750 → $564,900
- Reported investor count: Unavailable → 2
-
0001013594-25-001175D · Oct 2, 2025 · Pooled Investment FundSold: $585,750